LoginSignup
IBA logo

IBA

Stock
Stock
ISIN: BE0003766806
Ticker: IBAB
BE0003766806
IBAB

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 01.07.2026

$0.607

CHART BY

Frequently asked questions

What is IBA's market capitalization?

The market capitalization of IBA is $549.30M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is IBA's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for IBA is 27.30. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for IBA?

IBA's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.687. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for IBA's stock?

Currently, 3 analysts cover IBA's stock, with a consensus target price of $19.26. Analyst ratings provide insights into the stock's expected performance.

What is IBA's revenue over the trailing twelve months?

Over the trailing twelve months, IBA reported a revenue of $703.36M.

What is the EBITDA for IBA?

IBA's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $47.56M. EBITDA measures the company's overall financial performance.

What is the free cash flow of IBA?

IBA has a free cash flow of -$3.59M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does IBA have, and what sector and industry does it belong to?

IBA employs approximately 2,118 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of IBA's shares?

The free float of IBA is 18.13M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$549.30M
EPS (TTM) 
$0.687
Free Float 
18.13M
P/E ratio (TTM) 
27.30
Revenue (TTM) 
$703.36M
EBITDA (TTM) 
$47.56M
Free Cashflow (TTM) 
-$3.59M

Pricing

1D span
$17.94$18.79
52W span
$10.25$18.71

Analyst Ratings

The price target is $19.26 and the stock is covered by 3 analysts.

Buy

2

Hold

1

Sell

0

Information

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment include development, fabrication, and services associated with medical and industrial particle accelerators and proton therapy systems. The Dosimetry segment comprises activities that offer a full range of solutions and services that maximize efficiency and minimize errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company was founded by Yves Jongen on March 28, 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Employees
2,118
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
BE0003766806
Primary Ticker
IBAB

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin